Cargando…
Comparison of the injection‐site experience of semaglutide in a single‐dose and a multidose pen‐injector
Autores principales: | Snitker, Søren, Andersen, Andreas, Lindskov, Pernille Skøtt, van Marle, Sjoerd, Sode, Birgitte Fischer, Sparre, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545130/ https://www.ncbi.nlm.nih.gov/pubmed/35434913 http://dx.doi.org/10.1111/dom.14718 |
Ejemplares similares
-
Comparison of the injection‐site experience of the starting doses with semaglutide and dulaglutide: A randomized, double‐blind trial in healthy subjects
por: Snitker, Søren, et al.
Publicado: (2021) -
Semaglutide single‐dose pen‐injector: Post hoc analysis of summative usability testing for weight management
por: Klonoff, David C., et al.
Publicado: (2021) -
Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
por: Klonoff, David C, et al.
Publicado: (2020) -
Ease‐of‐use and acceptability of the novel semaglutide 2.4 mg single‐dose pen‐injector in people with overweight or obesity in the STEP 8 phase III trial
por: Snitker, Søren, et al.
Publicado: (2022) -
Factors Affecting Performance of Insulin Pen Injector Technology: A
Narrative Review
por: Sparre, Thomas, et al.
Publicado: (2022)